Start Date: 2025-01-04
End Date: 2025-01-10

Top Headlines

Main Stories

Canada-Saskatchewan Agreement on Rare Disease Drugs

The Government of Canada has signed a $40 million bilateral agreement with Saskatchewan to enhance access to medications for rare diseases. This initiative aims to support early diagnosis and screening, and initial funding includes drugs like Poteligeo, Oxlumo, and Epkinly. The agreement marks a commitment to improving healthcare accessibility and affordability, particularly for rare disease treatments, with further drug listings following pan-Canadian price negotiations.

Sources: ['Announcements: www.canada.ca']